Dimensional Fund Advisors’s Neumora Therapeutics NMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$333K Sell
557,334
-20,281
-4% -$28.1K ﹤0.01% 2994
2026
Q2
$982K Buy
577,615
+222,765
+63% +$424K ﹤0.01% 2867
2026
Q1
$692K Buy
354,850
+247,600
+231% +$642K ﹤0.01% 2902
2025
Q4
$192K Buy
107,250
+2,267
+2% +$4.96K ﹤0.01% 3095
2025
Q3
$191K Hold
104,983
– – ﹤0.01% 3125
2025
Q2
$77K Sell
104,983
-83,435
-44% -$63.2K ﹤0.01% 3206
2025
Q1
$188K Buy
+188,418
New +$323K ﹤0.01% 3139

Other funds holding NMRA

Dimensional Fund Advisors's NMRA Position: Q3 2026 in Review

Dimensional Fund Advisors reduced its Neumora Therapeutics (NMRA) stake by 3.5% in Q3 2026, selling an estimated $28.1K and leaving 557,334 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #2994.

Dimensional Fund Advisors first reported a position in NMRA in Q1 2025 and has held it in 7 quarters since. The position peaked at $982K in Q2 2026. 90 funds tracked by Wall St. Rank hold NMRA as of Q3 2026.

  • Dimensional Fund Advisors held 557,334 shares of Neumora Therapeutics worth $333K as of Q3 2026.
  • Dimensional Fund Advisors sold 20,281 Neumora Therapeutics shares in Q3 2026, an estimated $28.1K.
  • Neumora Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2994 holding.
  • Dimensional Fund Advisors first reported a position in Neumora Therapeutics in Q1 2025 and has held it in 7 quarters since.
  • Dimensional Fund Advisors's Neumora Therapeutics position peaked at $982K in Q2 2026.
  • 90 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.